<HashMap><database>biostudies-literature</database><scores/><additional><submitter>He R</submitter><funding>NCI NIH HHS</funding><pagination>2051-6</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3117672</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>5(12)</volume><pubmed_abstract>Tuberculosis (TB), which is caused by Mycobacterium tuberculosis (Mtb), is a major worldwide threat to public health. Mycobacterium protein tyrosine phosphatase B (mPTPB) is a virulent phosphatase secreted by Mtb, which is essential for the survival and persistence of the bacterium in the host. Consequently, small-molecule inhibitors of mPTPB are expected to serve as anti-TB agents with a novel mode of action. Herein, we report the discovery of highly potent and selective mPTPB inhibitors using a novel, double Click chemistry strategy. The most potent mPTPB inhibitor from this approach possesses a K(i) value of 160 nM and a >25-fold selectivity for mPTPB over 19 other protein tyrosine phosphatases (PTBs). Molecular docking study of the enzyme-inhibitor complex provides a rationale for the </pubmed_abstract><journal>ChemMedChem</journal><pubmed_title>Double click reaction for the acquisition of a highly potent and selective mPTPB inhibitor.</pubmed_title><pmcid>PMC3117672</pmcid><funding_grant_id>R01 CA126937</funding_grant_id><funding_grant_id>CA69202</funding_grant_id><funding_grant_id>R01 CA069202</funding_grant_id><funding_grant_id>CA126937</funding_grant_id><pubmed_authors>Zeng LF</pubmed_authors><pubmed_authors>Wu L</pubmed_authors><pubmed_authors>He Y</pubmed_authors><pubmed_authors>Gunawan AM</pubmed_authors><pubmed_authors>Zhang ZY</pubmed_authors><pubmed_authors>Jiang ZX</pubmed_authors><pubmed_authors>Yu Z</pubmed_authors><pubmed_authors>He R</pubmed_authors><pubmed_authors>Xu J</pubmed_authors><pubmed_authors>Wang L</pubmed_authors></additional><is_claimable>false</is_claimable><name>Double click reaction for the acquisition of a highly potent and selective mPTPB inhibitor.</name><description>Tuberculosis (TB), which is caused by Mycobacterium tuberculosis (Mtb), is a major worldwide threat to public health. Mycobacterium protein tyrosine phosphatase B (mPTPB) is a virulent phosphatase secreted by Mtb, which is essential for the survival and persistence of the bacterium in the host. Consequently, small-molecule inhibitors of mPTPB are expected to serve as anti-TB agents with a novel mode of action. Herein, we report the discovery of highly potent and selective mPTPB inhibitors using a novel, double Click chemistry strategy. The most potent mPTPB inhibitor from this approach possesses a K(i) value of 160 nM and a >25-fold selectivity for mPTPB over 19 other protein tyrosine phosphatases (PTBs). Molecular docking study of the enzyme-inhibitor complex provides a rationale for the </description><dates><release>2010-01-01T00:00:00Z</release><publication>2010 Dec</publication><modification>2026-04-30T22:28:17.265Z</modification><creation>2026-04-07T16:22:48.713Z</creation></dates><accession>S-EPMC3117672</accession><cross_references><pubmed>20957718</pubmed><doi>10.1002/cmdc.201000348</doi></cross_references></HashMap>